Séverine Bompoint

15.9k total citations · 2 hit papers
13 papers, 1.3k citations indexed

About

Séverine Bompoint is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Epidemiology. According to data from OpenAlex, Séverine Bompoint has authored 13 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Endocrinology, Diabetes and Metabolism, 3 papers in Cardiology and Cardiovascular Medicine and 3 papers in Epidemiology. Recurrent topics in Séverine Bompoint's work include Diabetes Treatment and Management (5 papers), Blood Pressure and Hypertension Studies (3 papers) and Traumatic Brain Injury and Neurovascular Disturbances (2 papers). Séverine Bompoint is often cited by papers focused on Diabetes Treatment and Management (5 papers), Blood Pressure and Hypertension Studies (3 papers) and Traumatic Brain Injury and Neurovascular Disturbances (2 papers). Séverine Bompoint collaborates with scholars based in Australia, United Kingdom and United States. Séverine Bompoint's co-authors include Bruce Neal, Meg Jardine, Kenneth W. Mahaffey, Brendon L. Neuen, Vlado Perkovic, Clare Arnott, Laurent Billot, Anthony Rodgers, David M. Charytan and David C. Wheeler and has published in prestigious journals such as JAMA, PLoS ONE and Journal of Hypertension.

In The Last Decade

Séverine Bompoint

13 papers receiving 1.3k citations

Hit Papers

SGLT2 inhibitors for the prevention of kidney failure i... 2015 2026 2018 2022 2019 2015 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: a systematic review and meta-analysis
    2019 600 citations Brendon L. Neuen, T. Kue Young et al. The Lancet Diabetes & Endocrinology profile →
  2. Effect of Lifestyle-Focused Text Messaging on Risk Factor Modification in Patients With Coronary Heart Disease
    2015 481 citations Clara K Chow, Julie Redfern et al. JAMA profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Séverine Bompoint Australia 8 670 339 305 282 214 13 1.3k
J. David Powers United States 17 295 0.4× 958 2.8× 187 0.6× 401 1.4× 172 0.8× 39 2.0k
Xiaohui Zhuo United States 17 702 1.0× 171 0.5× 280 0.9× 152 0.5× 151 0.7× 32 1.8k
Julie M. Paik United States 26 530 0.8× 172 0.5× 104 0.3× 305 1.1× 180 0.8× 83 1.7k
Abhinav Goyal United States 23 562 0.8× 931 2.7× 144 0.5× 237 0.8× 142 0.7× 77 1.8k
José León Spain 11 1.6k 2.4× 188 0.6× 128 0.4× 530 1.9× 331 1.5× 22 2.2k
Van Doren Hsu United States 18 313 0.5× 249 0.7× 165 0.5× 101 0.4× 103 0.5× 37 1.5k
Nuha A. ElSayed United States 15 1.9k 2.8× 216 0.6× 182 0.6× 598 2.1× 372 1.7× 24 2.6k
Sonia Butalia Canada 20 1.1k 1.6× 321 0.9× 135 0.4× 388 1.4× 169 0.8× 63 1.9k
Ranee Chatterjee United States 18 622 0.9× 445 1.3× 530 1.7× 187 0.7× 250 1.2× 65 2.1k
Todd Gress United States 14 520 0.8× 652 1.9× 151 0.5× 248 0.9× 100 0.5× 50 1.5k

Countries citing papers authored by Séverine Bompoint

Since Specialization
Citations

This map shows the geographic impact of Séverine Bompoint's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Séverine Bompoint with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Séverine Bompoint more than expected).

Fields of papers citing papers by Séverine Bompoint

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Séverine Bompoint. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Séverine Bompoint. The network helps show where Séverine Bompoint may publish in the future.

Co-authorship network of co-authors of Séverine Bompoint

This figure shows the co-authorship network connecting the top 25 collaborators of Séverine Bompoint. A scholar is included among the top collaborators of Séverine Bompoint based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Séverine Bompoint. Séverine Bompoint is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Hammond, Naomi, Sheetal Agarwal, Sean C. Taylor, et al.. (2024). Sepsis associated acute kidney injury is common among Aboriginal and Torres Strait Islanders with septic shock and has poor outcomes: A nested cohort study. Nephrology. 29(12). 1000–1004. 1 indexed citations
2.
Hackett, Maree L., Graeme J. Hankey, Erik Lundström, et al.. (2022). Repeated Measures of Modified Rankin Scale Scores to Assess Functional Recovery From Stroke: AFFINITY Study Findings. Journal of the American Heart Association. 11(16). e025425–e025425. 14 indexed citations
3.
Hammond, Naomi, Sean C. Taylor, Séverine Bompoint, et al.. (2022). Outcomes following severe septic shock in a cohort of Aboriginal and Torres Strait Islander people: a nested cohort study from the ADRENAL trial. Critical Care and Resuscitation. 24(1). 20–28. 4 indexed citations
4.
Arnott, Clare, Qiang Li, Amy Kang, et al.. (2020). Sodium‐Glucose Cotransporter 2 Inhibition for the Prevention of Cardiovascular Events in Patients With Type 2 Diabetes Mellitus: A Systematic Review and Meta‐Analysis. Journal of the American Heart Association. 9(3). e014908–e014908. 161 indexed citations
5.
Neuen, Brendon L., T. Kue Young, Hiddo J.L. Heerspink, et al.. (2019). SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: a systematic review and meta-analysis. The Lancet Diabetes & Endocrinology. 7(11). 845–854. 600 indexed citations breakdown →
6.
Webster, Jacqui, Séverine Bompoint, Claire Johnson, et al.. (2016). Salt Intakes, Knowledge, and Behavior in Samoa: Monitoring Salt‐Consumption Patterns Through the World Health Organization's Surveillance of Noncommunicable Disease Risk Factors (STEPS). Journal of Clinical Hypertension. 18(9). 884–891. 21 indexed citations
7.
Patel, Anushka, Séverine Bompoint, Alex Brown, et al.. (2015). The Effect of a Cardiovascular Polypill Strategy on Pill Burden. Cardiovascular Therapeutics. 33(6). 347–352. 24 indexed citations
8.
Saxena, Manoj, Colman Taylor, Laurent Billot, et al.. (2015). The Effect of Paracetamol on Core Body Temperature in Acute Traumatic Brain Injury: A Randomised, Controlled Clinical Trial. PLoS ONE. 10(12). e0144740–e0144740. 20 indexed citations
9.
Chow, Clara K, Julie Redfern, Graham S. Hillis, et al.. (2015). Effect of Lifestyle-Focused Text Messaging on Risk Factor Modification in Patients With Coronary Heart Disease. JAMA. 314(12). 1255–1255. 481 indexed citations breakdown →
10.
11.
Chalmers, John, Rohina Joshi, André Pascal Kengne, et al.. (2008). Efficacité et tolérance de lʼassociation fixe perindopril / indapamide dans le diabète de type 2: résultats de lʼétude ADVANCE. Journal of Hypertension. 26(Suppl 3). S23–S30. 2 indexed citations
12.
Chalmers, John, Rohina Joshi, André Pascal Kengne, et al.. (2008). Efficacy and safety of fixed combination of perindopril and indapamide in type 2 diabetes: results from ADVANCE in context of available evidence. Journal of Hypertension. 26(Suppl 3). S21–S27. 8 indexed citations
13.
Chalmers, John, Rohina Joshi, André Pascal Kengne, et al.. (2008). Efficacy and safety of fixed combination of perindopril and indapamide in type 2 diabetes: results from ADVANCE in context of evidence available in 2007. Journal of Hypertension. 26. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J. David Powers Breakdown of academic impact, for papers by Xiaohui Zhuo Breakdown of academic impact, for papers by Julie M. Paik Breakdown of academic impact, for papers by Abhinav Goyal Breakdown of academic impact, for papers by José León Breakdown of academic impact, for papers by Van Doren Hsu Breakdown of academic impact, for papers by Nuha A. ElSayed Breakdown of academic impact, for papers by Sonia Butalia Breakdown of academic impact, for papers by Ranee Chatterjee Breakdown of academic impact, for papers by Todd Gress
Rankless by CCL
2026